Psychometric validation of the Psoriasis Symptom Diary using Phase III study data from patients with chronic plaque psoriasis
Bruce Strober(Yale University), Mark Lebwohl(Mount Sinai Hospital), Lori McLeod(RTI International), Margaret Mordin(RTI Health Solutions), C. Papavassilis(Novartis (Switzerland)), Alice B. Gottlieb(The University of Texas Southwestern Medical Center), Mary Helen Tran(Sanofi (United States)), Judit Nyirady(Novartis (Switzerland)), Yang Zhao(Xi'an Jiaotong University), Ari Gnanasakthy(RTI Health Solutions), Lauren Nelson(RTI Health Solutions), Boni E. Elewski(University of Alabama at Birmingham)
Cited by 17
Related Papers
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
|Journal of the American Academy of Dermatology|2019|917
Psoriasis
|Nature Reviews Disease Primers|2016|893
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research
|Quality of Life Research|2013|855
Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults
|Journal of the American Academy of Dermatology|2016|564
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities
|Journal of the American Academy of Dermatology|2019|484